Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection inrare disease

20227 citationsJournal Articlegold Open Access

Authors

Erika Tarasco · University of Bern

Anne Sophie von Krogh · Norwegian University of Science and Technology

Radomíra Hrdličková · University Hospital Ostrava

Thomas R. Braschler · Luzerner Kantonsspital

Teresa Iwaniec · Jagiellonian University

Paul Knöbl · Medical University of Vienna

Eriko Hamada

Abstract

The risk of an acute episode triggered by COVID-19 seems higher than following vaccination in hTTP patients, who can be safely vaccinated against SARS-CoV-2.

Topics & Keywords

Complement system in diseases Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Research and Practice in Thrombosis and Haemostasis

Volume 6, Issue 7, pp. e12814-e12814

DOI: 10.1002/rth2.12814

Field-Weighted Citation Impact: 0.59